EIR Chongqing Daxin Pharmaceutical Sep 2001

Charles Edwards FDA, Yvette Johnson FDA$595.00 - Available Now

FDA investigators audited the Chongqing Daxin Pharmaceutical - Chongqing, China facility and issued inspectional observation (via FDA 483) on 25 Sep 2001.

Product details

  • Category:
  • Inspection end: 25 Sep 2001
  • Location: Chongqing, China
  • FEI: 3002806683
Add To Cart